Therefore, regardless of the upstream signals, the aforementioned findings and our results suggest that TGF-β1, Src, and fibronectin could work in concert to shape a mesenchymal-like morphology and predispose RCC cells to cell growth and migration, involving induction of cyclin D1, vimentin, and other unidentified molecules. The gene discussed is VIM; the disease is renal cell carcinoma.